Evidence map›Paper›PMID 14755036›Full record

ArticleSexually transmitted infections2004

Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

M M Barousse, B J Van Der Pol, D Fortenberry, D Orr, P L Fidel

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Sexually transmitted infections, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Discovering a new paradigm: Gut microbiota as a central modulator of sexual health.World journal of gastrointestinal pathophysiology · 2025
    Review
  4. Review
  5. Frontiers in parasitology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. The emerging threat antifungal-resistantFrontiers in fungal biology · 2022
    Review
  12. Journal of fungi (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Review
  15. Gender differences in risk taking behaviors forHealth care for women international · 2020
    Article
  16. Review
  17. Review
  18. On Commensalism ofJournal of fungi (Basel, Switzerland) · 2020
    Review
  19. Local ProbioticFrontiers in microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M M BarousseDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA.
B J Van Der Pol
D Fortenberry
D Orr
P L Fidel
Louisiana State University Health Sciences Center New Orleans · US

Funding

PYSCHOPHYSICAL, PARTNER SPECIFIC &COITUS SPECIFIC RISK &PROTECTIVE FACTORSU19AI043924 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ORR, DONALD P · 1998 to 2003
$5.6M
NIAID NIH HHS U19 AI43924
6 · The paper itself

Abstract

objectivesTo evaluate point prevalence vaginal yeast colonisation and symptomatic vaginitis in middle adolescents and to identify relation of these yeast conditions with reproductive hormones, sexual activity, sexual behaviours, and associated local immunity.

methodsMiddle adolescent females (n = 153) were evaluated for sexually transmitted infections (STIs), asymptomatic yeast colonisation, and symptomatic vulvovaginal candidiasis (VVC) by standard criteria. Also evaluated were local parameters, including vaginal associated cytokines, chemokines, and antibodies, vaginal epithelial cell antifungal activity, and Candida specific peripheral blood lymphocyte responses. Correlations between yeast colonisation/vaginitis and local immunomodulators, reproductive hormones, douching, sexual activity, condom use, and STIs were identified.

resultsRates of point prevalence asymptomatic yeast colonisation (22%) were similar to adults and similarly dominated by Candida albicans, but with uncharacteristically high vaginal yeast burden. In contrast with the high rate of STIs (18%), incidence of symptomatic VVC was low (<2%). Immunological properties included high rates of Candida specific systemic immune sensitisation, a Th2 type vaginal cytokine profile, total and Candida specific vaginal antibodies dominated by IgA, and moderate vaginal epithelial cell anti-Candida activity. Endogenous reproductive hormones were in low concentration. Sexual activity positively correlated with vaginal yeast colonisation, whereas vaginal cytokines (Th1, Th2, proinflammatory), chemokines, antibodies, contraception, douching, or condom use did not.

conclusionAsymptomatic vaginal yeast colonisation in adolescents is distinct in some ways with adults, and positively correlates with sexual activity, but not with local immunomodulators or sexual behaviours. Despite several factors predictive for VVC, symptomatic VVC was low compared to STIs.

Indexed as

AdolescentAntibodies, FungalAntibody FormationCandidiasis, VulvovaginalChemokinesCondomsCytokinesFemaleHumansIndianaMenstrual CyclePrevalenceSexual BehaviorSexual PartnersVaginal DouchingVaginitisAntibodies, FungalChemokinesCytokines

Identifiers

PMID14755036
PMCPMC1758371
OpenAlexW2147560182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.